Select Pharmaceuticals Portfolio (FPHAX) is an MF managed by Fidelity. Its largest position is ELI LILLY & Co (LLY), representing 25.18% of fund assets.
Select Pharmaceuticals Portfolio Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FPHAX
- Type:
- MF
- Manager:
- Fidelity
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
25.18% | $381,663,023.99 | 362,801 |
|
-
GSK plc
|
10.07% | $152,635,816.80 | 2,581,360 |
|
-
JOHNSON & JOHNSON
|
7.53% | $114,203,271.00 | 459,700 |
|
-
APPLIED MATERIALS INC /DE
|
5.01% | $75,870,949.38 | 254,500 |
|
-
APPLIED MATERIALS INC /DE
|
4.93% | $74,759,359.77 | 157,090 |
|
-
ASTRAZENECA PLC
|
4.93% | $74,677,212.50 | 358,250 |
|
-
GILEAD SCIENCES, INC.
|
4.64% | $70,378,875.00 | 472,500 |
|
-
Merck & Co., Inc.
|
4.59% | $69,529,387.52 | 561,536 |
|
-
Elanco Animal Health Inc
|
4.42% | $66,955,680.00 | 2,536,200 |
|
-
FIDELITY REVERE STREET TRUST
|
4.26% | $64,535,363.81 | 64,528,911 |
|
-
Legend Biotech Corp
|
3.26% | $49,369,600.00 | 2,598,400 |
|
-
Jazz Pharmaceuticals plc
|
2.85% | $43,267,554.00 | 227,700 |
|
-
Moderna, Inc.
|
2.43% | $36,899,016.00 | 688,800 |
|
-
Royalty Pharma plc
|
2.29% | $34,680,605.00 | 750,500 |
|
-
Viatris Inc
|
1.70% | $25,822,928.00 | 1,729,600 |
|
-
APPLIED MATERIALS INC /DE
|
1.62% | $24,511,648.56 | 91,587 |
|
-
BioNTech SE
|
0.96% | $14,622,340.19 | 132,653 |
|
-
APPLIED MATERIALS INC /DE
|
0.95% | $14,348,541.37 | 94,700 |
|
-
BIOGEN INC.
|
0.92% | $14,002,860.00 | 73,000 |
|
-
OCULAR THERAPEUTIX, INC
|
0.79% | $11,905,549.98 | 1,331,717 |
|
-
Beam Therapeutics Inc.
|
0.78% | $11,822,284.00 | 415,400 |
|
-
Xenon Pharmaceuticals Inc.
|
0.77% | $11,611,578.00 | 268,600 |
|
-
uniQure N.V.
|
0.73% | $11,028,184.14 | 705,578 |
|
-
CAPRICOR THERAPEUTICS, INC.
|
0.72% | $10,889,907.00 | 389,900 |
|
-
PTC THERAPEUTICS, INC.
|
0.70% | $10,610,364.00 | 155,600 |
|
-
Kymera Therapeutics, Inc.
|
0.61% | $9,317,700.00 | 102,000 |
|
-
PHIBRO ANIMAL HEALTH CORP
|
0.54% | $8,229,715.45 | 150,755 |
|
-
Axsome Therapeutics, Inc.
|
0.53% | $8,014,221.00 | 48,900 |
|
-
Annexon, Inc.
|
0.47% | $7,078,960.00 | 1,264,100 |
|
-
Ascendis Pharma A/S
|
0.38% | $5,697,400.00 | 24,400 |
|
-
CORCEPT THERAPEUTICS INC
|
0.37% | $5,644,170.00 | 158,100 |
|
-
APPLIED MATERIALS INC /DE
|
0.35% | $5,332,386.09 | 332,858 |
|
-
Intellia Therapeutics, Inc.
|
0.35% | $5,298,410.00 | 384,500 |
|
-
CRINETICS PHARMACEUTICALS INC
|
0.33% | $5,047,080.00 | 122,800 |
|
-
FIDELITY REVERE STREET TRUST
|
0.32% | $4,810,346.21 | 4,809,384 |
|
-
Harmony Biosciences Holdings, Inc.
|
0.30% | $4,525,787.58 | 158,577 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.27% | $4,137,858.00 | 65,400 |
|
-
Wave Life Sciences, Inc.
|
0.27% | $4,134,424.00 | 296,800 |
|
-
Vera Therapeutics, Inc.
|
0.27% | $4,107,553.00 | 100,700 |
|
-
Amylyx Pharmaceuticals, Inc.
|
0.26% | $3,910,826.00 | 257,800 |
|
-
Disc Medicine, Inc.
|
0.24% | $3,584,156.00 | 53,800 |
|
-
Definium Therapeutics, Inc.
|
0.22% | $3,280,600.00 | 188,000 |
|
-
APPLIED MATERIALS INC /DE
|
0.21% | $3,257,161.87 | 639,660 |
|
-
Summit Therapeutics Inc.
|
0.19% | $2,808,753.36 | 169,304 |
|
-
Edgewise Therapeutics, Inc.
|
0.17% | $2,544,784.00 | 83,600 |
|
-
ArriVent BioPharma, Inc.
|
0.16% | $2,457,790.00 | 107,000 |
|
-
Viking Therapeutics, Inc.
|
0.14% | $2,175,912.00 | 64,300 |
|
-
APPLIED MATERIALS INC /DE
|
0.10% | $1,480,752.28 | 158,879 |
|
-
APPLIED MATERIALS INC /DE
|
0.09% | $1,418,038.40 | 6,308 |
|
-
APPLIED MATERIALS INC /DE
|
0.06% | $960,098.85 | 56,643 |
Advertisement (320x50)